As-needed versus regular intranasal corticosteroid for allergic rhinitis: A systematic review and meta-analysis
Daily intranasal corticosteroid (INCS) is recommended for treating allergic rhinitis (AR). Nevertheless, patients are generally not adherent and use it on-demand. The data on the efficacy of as-needed INCS was insufficient.